During the past decade, Valley Radiation Oncology conducted 165 clinical trials. In the 10-year time frame, 165 clinical trials started and 88 clinical trials were completed, i.e. on average, 53.3% percent of trials that started reached the finish line to date. In the past 5 years, 71 clinical trials started and 63 clinical trials were completed. i.e. 88.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Valley Radiation Oncology" #1 sponsor was "National Cancer Institute (NCI)" with 104 trials, followed by "Alliance for Clinical Trials in Oncology" with 40 trials sponsored, "SWOG Cancer Research Network" with 39 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 20 trials sponsored and "GOG Foundation" with 20 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Valley Radiation Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 124 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Valley Radiation Oncology" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Recurrent Breast Carcinoma" (9 trials), "Invasive Breast Carcinoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Valley Radiation Oncology" in a lesser frequency.

Most popular intervention types in "Valley Radiation Oncology" are "Drug" (182 trials), "Other" (144 trials), "Biological" (87 trials), "Procedure" (61 trials) and "Radiation" (33 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (72 trials), "Quality-of-Life Assessment" (56 trials), "Questionnaire Administration" (38 trials), "Computed Tomography" (32 trials) and "Biospecimen Collection" (31 trials). Other intervention names were less common.

The vast majority of trials in "Valley Radiation Oncology" are 187 trials for "All" genders, 39 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Valley Radiation Oncology". undefined are not yet recruiting, 69 are recruiting, 101 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Valley Radiation Oncology, 6 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Valley Radiation Oncology, 12 "Phase 1" clinical trials were conducted, 111 "Phase 2" clinical trials and 113 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".